7 days Harmony Bio, The No. 1 Biotech Stock, Surges On Its ‘High Quality’ BeatInvestor's Business Daily

Harmony Biosciences stock jumped Tuesday on the biotech company’s “high-quality” third-quarter beat on the back of its narcolepsy drug.
The post Harmony Bio, The No. 1 Biotech Stock, Surges On Its 'High Quality' Beat appeared first on Investo…

13 hours Why Summit Therapeutics Stock Was a Winner TodayThe Motley Fool X

13 hours Why Viking Therapeutics Stock Plummeted After Soaring TodayThe Motley Fool X

16 hours Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

18 hours Gilead Science to Report Q3 Earnings: What’s in the Cards?Zacks X

24 hours This Beaten-Down Stock Could Soar by 354%, According to Wall StreetThe Motley Fool X

2 days Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X

2 days Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO24/7 Wall St. X

3 days Is Recursion Pharmaceuticals a Millionaire-Maker Stock?The Motley Fool X

4 days ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting DebacleInvestor's Business Daily X

5 days Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars LoomInvestor's Business Daily X

5 days This High-Flying Stock Just Became a Better BuyThe Motley Fool X

6 days Why Guardant Health Stock Was the Picture of Health TodayThe Motley Fool X

7 days Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7%MarketBeat X

1 week Regeneron to Report Q3 Earnings: What’s in the Offing?Zacks X

1 week Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings?Zacks X

1 week Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?Zacks X

1 week Novo Holdings A S Has $3.52 Million Position in IO Biotech, Inc. (NASDAQ:IOBT)MarketBeat X

1 week Oncolytics Biotech Inc. (NASDAQ:ONCY) Sees Significant Increase in Short InterestMarketBeat X

1 week 3 Key Trends That Are Bullish for Recursion Pharmaceuticals StockThe Motley Fool X

1 week The Ultimate Biotech Stock to Buy With $50 Right NowThe Motley Fool X

1 week Legend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of “Buy” from AnalystsMarketBeat X

1 week U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small NamesSeeking Alpha X

2 weeks Why Intellia Therapeutics Stock Plummeted by 20% TodayThe Motley Fool X

2 weeks Why Viking Therapeutics Stock Soared by Nearly 21% on ThursdayThe Motley Fool X

2 weeks XBI: Biotech ETF Is A Must HaveSeeking Alpha X

2 weeks Zai Lab, A Top 6% Stock, Launched To A 16-Month High On Its ‘Impressive’ ResultsInvestor's Business Daily X

2 weeks Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug loomsMarketWatch X

2 weeks 5 Biotech Stocks Likely to Outperform as Industry Prospects Look BrightZacks X

2 weeks What sector do you think will be the next bubble?Reddit X

2 weeks 1 Brand-New Big Reason to Buy This Biotech Stock Right NowThe Motley Fool X

2 weeks Recursion Pharmaceuticals (RXRX): A Promising Small-Cap in Biotech InnovationInsider Monkey X

2 weeks Viridian Therapeutics (VRDN): A Small-Cap Biotech with Promising Clinical ResultsInsider Monkey X

2 weeks Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales GrowthInsider Monkey X

2 weeks Arvinas (ARVN): A Small-Cap Biotech with High Growth PotentialInsider Monkey X

2 weeks Legend Biotech (NASDAQ:LEGN) Shares Gap Up – Here’s WhyMarketBeat X

2 weeks Cabaletta: Biotech With Large Potential, Interesting Bottom Pattern, Plenty Of CashSeeking Alpha X

2 weeks Should You Invest in the VanEck Biotech ETF (BBH)?Zacks X

2 weeks Everence Capital Management Inc. Invests $557,000 in Krystal Biotech, Inc. (NASDAQ:KRYS)MarketBeat X

2 weeks Why Amgen (AMGN) Dipped More Than Broader Market TodayZacks X

2 weeks This Vaccine Stock Just Dropped by 20%: Should You Buy the Dip?The Motley Fool X

2 weeks Q3 EPS Estimates for Legend Biotech Boosted by HC WainwrightMarketBeat X

2 weeks Warren Buffett and Biotech IPOs Highlight Recent Insider Buying24/7 Wall St. X

2 weeks How Bad Is This News for Novavax?The Motley Fool X

3 weeks Why Enliven is this analyst’s top biotech stock pickYouTube X

3 weeks Pharma Stock Roundup: JNJ’s Q3 Earnings, FDA Nod to Some New DrugsZacks X

3 weeks All You Need to Know About Krystal Biotech (KRYS) Rating Upgrade to BuyZacks X

3 weeks Brokers Set Expectations for Legend Biotech FY2025 EarningsMarketBeat X

3 weeks Krane Funds Advisors LLC Sells 19,045 Shares of Legend Biotech Co. (NASDAQ:LEGN)MarketBeat X

3 weeks Why Amylyx Pharmaceuticals Stock Was So Healthy This WeekThe Motley Fool X

3 weeks Krystal Biotech, Inc. (NASDAQ:KRYS) Receives Consensus Rating of “Buy” from BrokeragesMarketBeat X